Add to ORKGPurpose: Advanced pancreatic cancer (APC) has a poor prognosis and chemotherapy remains the primary treatment modality. Gemcitabine (GEM) and 5-fluorouracil (5-FU) are the most active drugs in the treatment of pancreatic cancer This study evaluated the efficacy and tolerability of the combination of these agents in APC
Pancreatic cancer is a disease with high mortality. It is predicted to become the second leading cau...
Background: The aim of this study was to determine the activity of the combination of cisplatin, gem...
Abstract: Background: Laboratory evidences suggest the possibility that an infusion rate of 10 mg/m(...
Purpose: Advanced pancreatic cancer (APC) has a poor prognosis and chemotherapy remains the primary ...
Background: 5-Fluorouracil (5-FU) and gemcitabine are the major active drugs in the treatment of pan...
[[abstract]]Background: Pancreatic cancer is a dismal disease. Few drugs, including gemcitabine and ...
Background: Pancreatic cancer is a dismal disease. Few drugs , including gemcitabine and 5-fluoroura...
BACKGROUND AND OBJECTIVEThe response rate and median survival with gemcitabine monotherapy, although...
In a randomized clinical trial, gemcitabine (GEM) was more effective than 5-fluorouracil (5-FU) in a...
Background: In an effort to improve efficacy of single-agent gemcitabine in pancreatic cancer, sever...
Pancreatic adenocarcinoma is a common disease considered to be poorly responsive to antiblastic trea...
Aim: To determine the activity and toxicity of a combination of weekly gemcitabine and 5-fluorouraci...
Gemcitabine (GEM) is the standard first-line chemotherapy that provides limited clinical benefits fo...
Laboratory evidences suggest the possibility that an infusion rate of 10 mg/m2/min may be more effec...
To evaluate the efficacy and safety profile of a triplet regimen consisting of gemcitabine, oxalipla...
Pancreatic cancer is a disease with high mortality. It is predicted to become the second leading cau...
Background: The aim of this study was to determine the activity of the combination of cisplatin, gem...
Abstract: Background: Laboratory evidences suggest the possibility that an infusion rate of 10 mg/m(...
Purpose: Advanced pancreatic cancer (APC) has a poor prognosis and chemotherapy remains the primary ...
Background: 5-Fluorouracil (5-FU) and gemcitabine are the major active drugs in the treatment of pan...
[[abstract]]Background: Pancreatic cancer is a dismal disease. Few drugs, including gemcitabine and ...
Background: Pancreatic cancer is a dismal disease. Few drugs , including gemcitabine and 5-fluoroura...
BACKGROUND AND OBJECTIVEThe response rate and median survival with gemcitabine monotherapy, although...
In a randomized clinical trial, gemcitabine (GEM) was more effective than 5-fluorouracil (5-FU) in a...
Background: In an effort to improve efficacy of single-agent gemcitabine in pancreatic cancer, sever...
Pancreatic adenocarcinoma is a common disease considered to be poorly responsive to antiblastic trea...
Aim: To determine the activity and toxicity of a combination of weekly gemcitabine and 5-fluorouraci...
Gemcitabine (GEM) is the standard first-line chemotherapy that provides limited clinical benefits fo...
Laboratory evidences suggest the possibility that an infusion rate of 10 mg/m2/min may be more effec...
To evaluate the efficacy and safety profile of a triplet regimen consisting of gemcitabine, oxalipla...
Pancreatic cancer is a disease with high mortality. It is predicted to become the second leading cau...
Background: The aim of this study was to determine the activity of the combination of cisplatin, gem...
Abstract: Background: Laboratory evidences suggest the possibility that an infusion rate of 10 mg/m(...